National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 443788

History of Changes from the VAERS Wayback Machine

First Appeared on 3/12/2012

VAERS ID: 443788
Age:
Gender:Unknown
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2011-11-28
Entered:2011-11-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Abdominal pain, Pelvic inflammatory disease

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1111USA02627

Write-up:Information has been received from health authority (local reference No. NZL/11/0104) concerning a patient who on an unspecified date was vaccinated with a dose of GARDASIL (lot number, dose and site of administration not reported. No other medications were reported. On an unspecified date, the patient experienced abdominal pain and pelvic inflammation. At the time of the report, the patient''s abdominal pain and pelvic inflammation persisted. The reporter felt that abdominal pain and pelvic inflammation were related to therapy with GARDASIL. Abdominal pain and pelvic inflammation were considered to be disabling by the agency. The original reporting source was not provided. No further information is available.


Changed on 6/14/2014

VAERS ID: 443788 Before After
Age:
Gender:Unknown
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2011-11-28
Entered:2011-11-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Abdominal pain, Pelvic inflammatory disease

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1111USA02627

Write-up:Information has been received from health authority (local reference No. NZL/11/0104) concerning a patient who on an unspecified date was vaccinated with a dose of GARDASIL (lot number, dose and site of administration not reported. No other medications were reported. On an unspecified date, the patient experienced abdominal pain and pelvic inflammation. At the time of the report, the patient''s abdominal pain and pelvic inflammation persisted. The reporter felt that abdominal pain and pelvic inflammation were related to therapy with GARDASIL. Abdominal pain and pelvic inflammation were considered to be disabling by the agency. The original reporting source was not provided. No further information is available.


Changed on 3/14/2015

VAERS ID: 443788 Before After
Age:
Gender:Unknown
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2011-11-28
Entered:2011-11-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Abdominal pain, Pelvic inflammatory disease

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1111USA02627

Write-up:Information has been received from health authority (local reference No. NZL/11/0104) concerning a patient who on an unspecified date was vaccinated with a dose of GARDASIL (lot number, dose and site of administration not reported. No other medications were reported. On an unspecified date, the patient experienced abdominal pain and pelvic inflammation. At the time of the report, the patient''s abdominal pain and pelvic inflammation persisted. The reporter felt that abdominal pain and pelvic inflammation were related to therapy with GARDASIL. Abdominal pain and pelvic inflammation were considered to be disabling by the agency. The original reporting source was not provided. No further information is available.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=443788&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166